Photo of: Lan Chen

Dr. Lan Bo Chen This is Me

View Title...

Harvard Medical School's Dana-Farber Cancer Institute

Please Note:
This profile was automatically generated using 72 references found on the Internet. This information has not been verified. Learn more...

Employment History

View...

Board Membership and Affiliations

View...

Education

View...

 View all 72 references Web References

  1. 1. Synta Pharmaceuticals Corp.
    www.syntapharma.com/AboutUsHis - [Cached]

    Published on: 7/23/2008   Last Visited: 7/23/2008

    In 1992, Dr. Lan Bo Chen, a Professor of Pathology at Harvard Medical School's Dana-Farber Cancer Institute and Synta's scientific founder, co-founded a joint venture with a Japanese company to discover and develop novel drug candidates.This joint venture, structured as a majority-owned U.S.-based subsidiary of the Japanese parent company, brought together two essential elements for successful drug discovery: the scale, financial commitment, and chemistry expertise of the corporate partner; and the biology expertise of the co-founders, leading scientists from Harvard and MIT.

    The joint venture was sold in 1997 and many of the original team continued with Dr. Chen to found a similar venture called Shionogi BioResearch Corp with Shionogi & Co., Ltd, a major Japanese pharmaceutical company.
  2. 2. IntelliSoy - Research Group
    www.intellisoy.com/industry/co - [Cached]

    Published on: 3/11/2008   Last Visited: 3/11/2008

    Lan Bo ChenScientific AdvisorDr. Chen is both a prolific scientist and bioentrepreneur.A Professor of Pathology at Harvard Medical School's Dana-Farber Cancer Institute, Dr. Chen is an expert in mitochondria, the cytoskeleton, and cellular imaging techniques.He is the author of over 200 academic publications and the founder of five successful biotechnology companies, including Fuji ImmunoPharmaceuticals and Shionogi BioResearch (both with Nobel laureate Susumu Tonegawa at MIT).Dr. Chen has served as a senior consultant for numerous large pharmaceutical firms, and has led the development or consulted for more than a dozen drugs and drug candidates.
  3. 3. Synta Pharmaceuticals Corp. - Investor Relations - Corporate Governance
    ir.syntapharma.com/phoenix.zht - [Cached]

    Published on: 7/23/2008   Last Visited: 7/23/2008

    Dr. Bahcall co-founded Synta with Dr. Lan Bo Chen and has been Chief Executive Officer and a member of the board of directors since July 2001, and President since December 2003.
    ...
    Lan Bo Chen, Ph.D.Director, Scientific Founder, and Chairman of the Scientific Advisory

    Lan Bo Chen, Ph.D.Director, Scientific Founder, and Chairman of the Scientific Advisory

    Lan Bo Chen, Ph.D. co-founded Synta with Dr. Safi Bahcall and has been a member of the company's board of directors since July 2001, and a member of Synta's scientific advisory board and its Chairman since July 2001.
    ...
    Dr. Chen is a Professor of Pathology, Emeritus, at Harvard Medical School.He has been at the Dana-Farber Cancer Institute and Harvard Medical School since July 1977.Dr. Chen is the founder of several biotechnology companies, including Fuji ImmunoPharmaceuticals Corp. and Shionogi ...

Recent Updates
People Updates  7-24-2008,   People Updates  7-23-2008,   People Updates  7-22-2008,   People Updates  7-21-2008,   People Updates  7-20-2008,   People Updates  7-19-2008,   People Updates  7-18-2008,   Recent People Updates
Recent Company Updates
Company Directory
Medical Devices & Equipment , Insurance , Software Development & Design ...